---
figid: PMC5576374__12967_2017_1281_Fig1_HTML
figlink: /pmc/articles/PMC5576374/figure/Fig1/
number: Fig. 1
caption: FLT3 kinase signaling pathway and sites blocked by FLT3 inhibitors. Sorafenib
  and quizartinib inhibit only FLT3–ITD mutations, while midostaurin, crenolanib,
  and gilteritinib inhibit both FLT3–ITD and FLT3 TKD mutations
pmcid: PMC5576374
papertitle: Molecular targeting in acute myeloid leukemia.
reftext: Seah H. Lim, et al. J Transl Med. 2017;15:183.
pmc_ranked_result_index: '62434'
pathway_score: 0.9158089
filename: 12967_2017_1281_Fig1_HTML.jpg
figtitle: FLT3 kinase signaling pathway and sites blocked by FLT3 inhibitors
year: '2017'
organisms: Homo sapiens
ndex: bd22ce6c-def5-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5576374__12967_2017_1281_Fig1_HTML.html
  '@type': Dataset
  description: FLT3 kinase signaling pathway and sites blocked by FLT3 inhibitors.
    Sorafenib and quizartinib inhibit only FLT3–ITD mutations, while midostaurin,
    crenolanib, and gilteritinib inhibit both FLT3–ITD and FLT3 TKD mutations
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FLT1
  - AKT1
  - MAP2K2
  - MAPK3
  - MTOR
  - AKT2
  - MAP2K1
  - AKT3
  - PIK3CG
  - PIK3R3
  - MAPK1
  - RAF1
  - STAT1
  - STAT5B
  - BRAF
  - ARAF
  - JAK1
  - PIK3CB
  - HRAS
  - STAT5A
  - STAT6
  - PIK3R6
  - NRAS
  - STAT2
  - PIK3CD
  - PIK3CA
  - STAT3
  - JAK3
  - JAK2
  - KRAS
  - STAT4
  - SRC
  - PIK3R5
  - PIK3R4
  - TYK2
  - Midostaurin
  - Quizartinib
  - Crenolanib
  - Tyrosine
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: FLT
  symbol: FLT
  source: hgnc_prev_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Src/JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: Src/JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: Src/JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: Src/JAK
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: Src/JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
chemicals:
- word: Midostaurin
  source: MESH
  identifier: C059539
- word: Quizartinib
  source: MESH
  identifier: C544967
- word: Crenolanib
  source: MESH
  identifier: C577197
- word: Tyrosine
  source: MESH
  identifier: D014443
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
